Cidara Therapeutics is using its proprietary Cloudbreak ® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a proprietary human antibody ...

Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, July 29, 2025, after the market closes, it will report results for the second quarter of 2025.